Comment on CMS-2026-1255-0001

Summary: The National Organization of Rheumatology Management (NORM) supports the proposed rule's efforts to standardize electronic prior authorizations and improve transparency and reporting metrics. However, they argue the proposal falls short of addressing the administrative burdens caused by the disconnect between medical and pharmacy benefit systems and urge CMS to retain formulary information in APIs.